Susquehanna International Group
ZLAB icon

Susquehanna International Group’s Zai Lab ZLAB Stock Holding History

Susquehanna International Group’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Buy
+11,200
New +$208K ﹤0.01% 11593
2025
Q4 		– Sell
-113,900
Closed -$3.86M – 13813
2025
Q3 		$3.86M Buy
113,900
+19,400
+21% +$668K ﹤0.01% 4531
2025
Q2 		$3.3M Buy
94,500
+61,800
+189% +$2.03M ﹤0.01% 4773
2025
Q1 		$1.18M Sell
32,700
-4,900
-13% -$151K ﹤0.01% 6833
2024
Q4 		$985K Sell
37,600
-300
-0.8% -$8.33K ﹤0.01% 6978
2024
Q3 		$915K Buy
37,900
+11,300
+42% +$214K ﹤0.01% 6989
2024
Q2 		$461K Buy
26,600
+6,400
+32% +$113K ﹤0.01% 8457
2024
Q1 		$324K Buy
20,200
+3,000
+17% +$63.2K ﹤0.01% 9541
2023
Q4 		$470K Buy
+17,200
New +$454K ﹤0.01% 8822
2023
Q3 		– Sell
-59,200
Closed -$1.64M – 13150
2023
Q2 		$1.64M Buy
59,200
+4,000
+7% +$131K ﹤0.01% 5566
2023
Q1 		$1.84M Sell
55,200
-24,200
-30% -$929K ﹤0.01% 5319
2022
Q4 		$2.44M Buy
79,400
+14,900
+23% +$470K ﹤0.01% 4361
2022
Q3 		$2.21M Buy
64,500
+39,700
+160% +$1.7M ﹤0.01% 4712
2022
Q2 		$860K Buy
24,800
+18,300
+282% +$645K ﹤0.01% 6902
2022
Q1 		$286K Sell
6,500
-1,300
-17% -$62.9K ﹤0.01% 10392
2021
Q4 		$490K Sell
7,800
-6,600
-46% -$560K ﹤0.01% 9273
2021
Q3 		$1.52M Sell
14,400
-300
-2% -$43.1K ﹤0.01% 6448
2021
Q2 		$2.6M Sell
14,700
-34,900
-70% -$5.61M ﹤0.01% 5341
2021
Q1 		$6.62M Buy
49,600
+22,500
+83% +$3.48M ﹤0.01% 3417
2020
Q4 		$3.67M Sell
27,100
-2,900
-10% -$295K ﹤0.01% 3963
2020
Q3 		$2.5M Sell
30,000
-35,800
-54% -$2.87M ﹤0.01% 4198
2020
Q2 		$5.4M Buy
+65,800
New +$4.45M ﹤0.01% 2896
2020
Q1 		– Sell
-5,600
Closed -$233K – 11006
2019
Q4 		$233K Buy
+5,600
New +$207K ﹤0.01% 8496
2019
Q2 		– Sell
-15,900
Closed -$469K – 10935
2019
Q1 		$469K Buy
+15,900
New +$435K ﹤0.01% 6408

Other funds holding ZLAB

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Susquehanna International Group's ZLAB Position: Q1 2026 in Review

Susquehanna International Group increased its Zai Lab (ZLAB) stake by 15% in Q1 2026, buying an estimated $155K and bringing the position to 65,248 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #7361.

Susquehanna International Group first reported a position in ZLAB in Q1 2020 and has held it in 21 quarters since. The position peaked at $5.62M in Q3 2021. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • Susquehanna International Group held 65,248 shares of Zai Lab worth $1.23M as of Q1 2026.
  • Susquehanna International Group bought 8,353 Zai Lab shares in Q1 2026, an estimated $155K.
  • Zai Lab made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7361 holding.
  • Susquehanna International Group first reported a position in Zai Lab in Q1 2020 and has held it in 21 quarters since.
  • Susquehanna International Group's Zai Lab position peaked at $5.62M in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.